Cytokinetics | Late-Stage Biopharmaceutical Company
Cytokinetics is a late-stage biopharmaceutical company committed to developing potential medicines that impact the mechanics of muscle and may improve the lives of people living with debilitating diseases.
Company | Cytokinetics
Cytokinetics is a biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining.
Pipeline | Cytokinetics
Cytokinetics scientists and collaborators are committed to high scientific and ethical publications standards and are dedicated to providing our science to the medical and scientific community through peer-reviewed journals and medical forums.
Mission - Cytokinetics
At Cytokinetics our research is focused to modulating proteins in the sarcomere, the fundamental unit of muscle contraction found within muscle cells. These crucial proteins are the keys to unlock the potential treatment of diseases that are caused by impaired muscle function.
Medicines and Research | Cytokinetics
Nov 18, 2024 · At Cytokinetics we are committed to rigorous research to elaborate on the safety and efficacy of our potential medicines. Over our 25-year history, we have conducted more than 100 clinical trials in partnership with hundreds of research institutions across the world, and are grateful to the tens of thousands of patients who have contributed to ...
Our Story | Timeline | Cytokinetics
Cytokinetics was founded in 1998 by pioneers in the field of muscle biology. View our timeline to see the full story of Cytokinetics.
Our Vision - Cytokinetics
Cytokinetics is working toward research based on science in developing potential medicines that empower muscle, empower lives & improve patient outcomes.
Careers - Cytokinetics
At Cytokinetics, we are committed to empowering patients and our employees alike. Employee passion and dedication are the driving force to achieve our mission, and our progress depends on the unique expertise and contributions of each individual.
Cytokinetics Announces 2025 Corporate Milestones and Vision 2030
Jan 13, 2025 · SOUTH SAN FRANCISCO, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK) today provided guidance for corporate milestones expected to occur in 2025 and outlined its aspirational Vision 2030, five-year strategic objectives designed to propel Cytokinetics to becoming the leading muscle-focused specialty biopharmaceutical ...
How Muscles Work | The Science Behind Muscles - Cytokinetics
Cytokinetics is expanding its drug discovery efforts to address defects in energy metabolism with new therapies. By doing so, we aim to address muscle dysfunction in a more wholistic and comprehensive manner.